IL6 and systemic sclerosis: In rheumatoid arthritis, the effects of TNF-α and IL-6 are observed regardless of the length of the disease, but in SSc, IL-6 may have a minimal role in patients with a long disease course and IL-13 may have a limited role during the early disease stages.